Verax Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Verax Biomedical Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3311
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Verax Biomedical Inc (Verax) is a developer of rapid tests for the detection of bacterial contaminants in tissues for transplantation, blood components, and cellular therapies. The company’s products include platelet pgd test, red cell pgd test and cell therapy PGD test. It uses the PGD technology to conduct its tests. Verax’s product platelet pgd test is used for the detection of bacterial contamination in platelets. Verax uses pan genera detection (PGD) technology during quality control testing to develop tests in order to detect the bacteria in blood components. The company operates through its laboratory facility located in Marlborough, the US. Verax is headquartered in Marlborough, Massachusetts, the US.

Verax Biomedical Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verax Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verax Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 8
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Verax Biomedical Raises USD11.4 Million in Venture Financing 10
Verax Biomedical Raises USD12.6 Million in Venture Financing 11
Verax Biomedical Raises USD4 Million in Venture Financing 12
Verax Biomedical Inc – Key Competitors 13
Verax Biomedical Inc – Key Employees 14
Verax Biomedical Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Key Facts 2
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verax Biomedical Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verax Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 8
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Verax Biomedical Raises USD11.4 Million in Venture Financing 10
Verax Biomedical Raises USD12.6 Million in Venture Financing 11
Verax Biomedical Raises USD4 Million in Venture Financing 12
Verax Biomedical Inc, Key Competitors 13
Verax Biomedical Inc, Key Employees 14

List of Figures
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Verax Biomedical Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Verax Biomedical Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Verax Biomedical Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tenaska Inc:電力:M&Aディール及び事業提携情報
    Summary Tenaska Inc (Tenaska) is an independent power development and energy marketing company. It develops, designs, finances, and manages and operates power plants. The company purchases and sells natural gas, electric capacity, energy, and renewable energy products; acquires, manages, and optimiz …
  • Alfa Laval AB (ALFA):企業の財務・戦略的SWOT分析
    Alfa Laval AB (ALFA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • HollyFrontier Corp (HFC):石油・ガス:M&Aディール及び事業提携情報
    Summary HollyFrontier Corp (HollyFrontier) is an independent energy company. It carries out crude oil refining and wholesale marketing of refined petroleum products. The company produces and markets high-value light products such as gasoline, diesel, jet fuel, specialty lubricant products, heavy pro …
  • Celsion Corp (CLSN)-医療機器分野:企業M&A・提携分析
    Summary Celsion Corp (Celsion) is an oncology company that focuses on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA based therapies and DNA-mediated immunotherapy. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (L …
  • 3M Company:企業の戦略・SWOT・財務分析
    3M Company - Strategy, SWOT and Corporate Finance Report Summary 3M Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Vilniaus Degtine AB:企業の戦略・SWOT・財務情報
    Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report Summary Vilniaus Degtine AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Gammon India Ltd (GAMMONIND):企業の財務・戦略的SWOT分析
    Gammon India Ltd (GAMMONIND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • ADDvise Group AB (ADDV A):医療機器:M&Aディール及び事業提携情報
    Summary ADDvise Group AB (ADDvise), formerly ADDvise Lab Solutions AB, is a medical device company that manufactures and markets healthcare and laboratory equipment. The company offers laboratory products such as laboratory equipments, furnishings, safety ventilation, centrifuges, climate chambers, …
  • Laboratoires Thea SA:企業の戦略的SWOT分析
    Laboratoires Thea SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Green Earth Technologies Inc (GETG):企業の財務・戦略的SWOT分析
    Summary Green Earth Technologies Inc (GET) is a clean technology company that develops and markets of bio-based performance and cleaning products. The company’s products include small engine oils, motor oils, lubrication and engine protection oils. It also provides wheel cleaner, hydrophobic car was …
  • Recro Pharma Inc (REPH):企業の財務・戦略的SWOT分析
    Recro Pharma Inc (REPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Pakistan Water and Power Development Authority-エネルギー分野:企業M&A・提携分析
    Summary Pakistan Water and Power Development Authority (WAPDA) is a government-owned public authority maintaining power and water in Pakistan. It is responsible for the development of hydel power and water sector projects in Pakistan. The authority plans and executes projects and schemes for the gen …
  • Geistlich Pharma AG:企業の戦略的SWOT分析
    Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Outotec Oyj:企業のM&A・事業提携・投資動向
    Outotec Oyj - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Outotec Oyj Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • LegoChem Biosciences Inc (141080):企業の財務・戦略的SWOT分析
    Summary LegoChem Biosciences Inc (LCB) is a bio pharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of anti …
  • Amphastar Pharmaceuticals Inc (AMPH):企業の財務・戦略的SWOT分析
    Amphastar Pharmaceuticals Inc (AMPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Collegium Pharmaceutical Inc (COLL):企業の財務・戦略的SWOT分析
    Collegium Pharmaceutical Inc (COLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • One Medical Group Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary One Medical Group Inc (One Medical) is a provider of medical and technology-enabled health care services. The company’s service offerings include primary and pediatric care, prenatal and women's health, nutrition and sports medicine, LGBT care, mental health, dermatology, family and integrat …
  • 8point3 Energy Partners LP (CAFD):電力:M&Aディール及び事業提携情報
    Summary 8point3 Energy Partners LP (8point3 Energy) is a renewable energy company that owns, operates and acquires solar energy generation projects. The company offers operation and maintenance, project development, and technical services. It operates residential, commercial, industrial, and utility …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆